These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 6186563)

  • 61. Antigen common to several species, recognized by a rat monoclonal antibody raised against syngeneic rat bladder tumor.
    Eto H; Saya H; Nakata M; Mizoguchi A; Kamidono S
    Int J Cancer; 1989 Sep; 44(3):454-9. PubMed ID: 2476403
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Effect of BCG and BCG-CWS on experimental urinary bladder tumors in rats (author's transl)].
    Kawakita J
    Nihon Hinyokika Gakkai Zasshi; 1979 Nov; 70(11):1259-77. PubMed ID: 529653
    [No Abstract]   [Full Text] [Related]  

  • 63. [Study on the thymic lymphocytes in the rats treated with bladder cancer-inducing BBN--in vitro effect of the thymus humoral factor].
    Wada S
    Nihon Hinyokika Gakkai Zasshi; 1983 May; 74(5):821-33. PubMed ID: 6620782
    [No Abstract]   [Full Text] [Related]  

  • 64. [Study on rosette formation of thymus lymphocytes in the rat treated with BBN inducing urinary bladder cancer. Effect of the thymus humoral factor in vitro].
    Ozaki Y
    Nihon Hinyokika Gakkai Zasshi; 1986 Mar; 77(3):392-402. PubMed ID: 3488463
    [No Abstract]   [Full Text] [Related]  

  • 65. Subcellular localization and characterization of interleukin-1 alpha produced by rat bladder cancer cells.
    Hojo H; Kaneko A; Kayagaki N; Saki M; Hashimoto Y
    Immunol Lett; 1994 Dec; 43(3):215-20. PubMed ID: 7721336
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Detection of interspecies cross-reactive bladder cancer associated antigens by rat monoclonal antibodies raised against syngeneic rat bladder cancer].
    Eto H; Hara I; Kamidono S
    Nihon Hinyokika Gakkai Zasshi; 1988 Apr; 79(4):599-605. PubMed ID: 2465427
    [No Abstract]   [Full Text] [Related]  

  • 67. Adherent suppressor cells in the blood of patients with bladder cancer.
    Herr HW
    J Urol; 1981 Oct; 126(4):457-60. PubMed ID: 6457159
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [The use of lyophilized blood serum for determining the 3-HAA antigen in patients with precancerous diseases and cancer of the bladder].
    Klimenko IA; Sakalo VS; Korosteleva TA; Belokhvostova AT; Sakalo AV
    Lik Sprava; 1992; (11-12):49-52. PubMed ID: 1292221
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Immunity to tumor antigens: potential implications in human neuroblastoma.
    Bernstein I; Hellström KE; Wright PW
    J Natl Cancer Inst; 1976 Sep; 57(3):711-5. PubMed ID: 135846
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Enhancement of natural cytotoxicity in lymphocytes from animals with carcinogen-induced bladder cancer.
    Droller MJ; Gomolka D
    J Urol; 1983 Mar; 129(3):625-9. PubMed ID: 6834565
    [TBL] [Abstract][Full Text] [Related]  

  • 71. High susceptibility of analbuminaemic rats to induced bladder cancer.
    Kakizoe T; Komatsu H; Honma Y; Niijima T; Kawachi T; Sugimura T; Nagase S
    Br J Cancer; 1982 Mar; 45(3):474-6. PubMed ID: 7073941
    [No Abstract]   [Full Text] [Related]  

  • 72. Lymphocyte blastogenic response to autologous tumor cells pretreated with neuraminidase in patients with gastric carcinoma.
    Akiyoshi T; Kawaguchi M; Miyazaki S; Tsuji H
    Oncology; 1980; 37(5):309-13. PubMed ID: 7443164
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Modulation of the shedding of a rat tumor-associated antigen by growth regulation and anti-cancer drugs.
    Shibata T; Micallef M; Chiba I; Hosokawa M; Kobayashi H
    Anticancer Drugs; 1993 Dec; 4(6):657-64. PubMed ID: 8298165
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Stimulation of autologous blood lymphocytes by malignant lymphoma cells and homogenates.
    Ludgate ME; Gough J
    Br J Cancer; 1976 Dec; 34(6):619-25. PubMed ID: 1008989
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Immunological characteristics of bladder cancer.
    Br Med J; 1972 Dec; 4(5839):502-3. PubMed ID: 4642784
    [No Abstract]   [Full Text] [Related]  

  • 76. Mixed lymphocyte-autologous tumor cell reaction with primary rat bladder tumors: difficulty in the discrimination of tumor-specific antigen.
    Endho N; Hojo H; Masuko T; Hashimoto Y
    Gan; 1982 Dec; 73(6):926-30. PubMed ID: 6186563
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Emergence of an epidermis-associated cell surface antigen in epithelial cells of the rat urinary bladder in carcinogenesis.
    Masuko T; Hashimoto Y
    J Natl Cancer Inst; 1981 Aug; 67(2):431-6. PubMed ID: 6943379
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Antigen characteristics of nitrosamine-induced urinary bladder cancer in rats.
    Hashimoto Y; Kitagawa HS
    Gan; 1979 Jun; 70(3):305-14. PubMed ID: 381090
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Effect of phenacetin and caffeine on the urinary bladder of rats treated with N-butyl-N-(4-hydroxybutyl)nitrosamine.
    Nakanishi K; Fukushima S; Shibata M; Shirai T; Ogiso T; Ito N
    Gan; 1978 Jun; 69(3):395-400. PubMed ID: 669140
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Inhibitory effect of an aromatic retinoic acid analog on urinary bladder carcinogenesis in rats treated with N-butyl-N-(4-hydroxybutyl)nitrosamine.
    Murasaki G; Miyata Y; Babaya K; Arai M; Fukushima S; Ito N
    Gan; 1980 Jun; 71(3):333-40. PubMed ID: 7418979
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.